DEBPRASAD DUTTA - Profile and Journalist Details
Find journalists that align with your industry, location and vision. Unlock DEBPRASAD DUTTA's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.
Get connected with journalists today
DEBPRASAD DUTTA
Verified
Research Scientist, Freelance
Bangalore
Beats
Biography
| Neuroscience Expert + Poetry practitioner + Probono strategist | Debprasad Dutta, known as Dr. Deb, is a Research Scientist at the Mazumdar Shaw Center for Translational Research (MSCTR) in Bangalore, India. He holds a PhD in Human Genetics from the National Institute of Mental Health & Neurosciences (NIMHANS). His doctoral work focused on the neuroimmunogenetic profile of Guillain-Barré syndrome. At MSCTR, he is involved in stem cell therapy development for neurological disorders with Narayana Health and participates in projects funded by SKAN Research Trust. His research interests include cell-based regeneration for stroke damage and biomarkers for stroke susceptibility. His awards include the Commonwealth Scholarship (UK), Developing Country Award (USA), and AWSAR Award (India). He also peer-reviews for journals such as Nature Scientific Reports. Beyond science, he is interested in poetry and public outreach on neuroscience.
Open to anything.
Content
By DEBPRASAD DUTTA, Research Scientist| Healthcare Executive@ The history of Guillain-Barré Syndrome (GBS) dates back to 1859, when French physician Jean Landry first documented what he described as “ascending paralysis” (later termed Landry paralysis). In 1916, neurologists Guillain, Barré, and Strohl observed World War I soldiers with mysterious paralysis and elevated cerebrospinal fluid (CSF) protein levels. Though all three contributed, later references omitted Strohl’s name, despite his role in the discovery.
Comparative Immunogenicity, Safety and Efficacy Profiles of four COVID-19 Vaccine types in healthy adults: Systematic Review cum Meta-analysis of Clinical Trial data
By Priyanka Bhowmik, DEBPRASAD DUTTA, Si Qi Yoong| medRxiv@ The authors have declared no competing interest. Not ApplicableSelf-funded. I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Company Info
Freelance
Freelancer.com is the largest freelancing and crowdsourcing marketplace in the world, connecting over 81 million employers and freelancers across more than 247 countries. Founded in 2009 and based in Sydney, Australia, the platform allows employers to post jobs while freelancers can bid on these projects. It is publicly traded on the Australian Securities Exchange under the ticker ASX:FLN. The platform supports a variety of work categories, including software development, writing, design, and marketing. Freelancer.com also offers contests for creative work, where employers can award prize money to winning entries. Users can choose from different membership plans, including free and paid subscriptions, which provide various benefits. The mobile app enhances project management and communication for users on the go. With a diverse customer base that includes individuals, small businesses, and large enterprises, Freelancer.com plays a significant role in the global online economy.
De Pere, Wisconsin, United States